Agilon Health, Inc. (NYSE:AGL) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Agilon Health, Inc. (NYSE:AGL) have earned an average rating of “Hold” from the nineteen brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $2.8077.

A number of research analysts have recently weighed in on the stock. Barclays cut their price target on shares of Agilon Health from $3.00 to $1.50 and set an “underweight” rating on the stock in a report on Wednesday, August 6th. Robert W. Baird lowered their target price on shares of Agilon Health from $5.00 to $1.00 and set a “neutral” rating on the stock in a research note on Thursday, August 14th. Sanford C. Bernstein reiterated a “market perform” rating and issued a $1.40 target price (down from $4.00) on shares of Agilon Health in a research note on Wednesday, August 20th. Wells Fargo & Company lowered their target price on shares of Agilon Health from $5.00 to $1.50 and set an “overweight” rating on the stock in a research note on Tuesday, October 7th. Finally, Evercore ISI lowered their target price on shares of Agilon Health from $5.00 to $3.00 and set an “in-line” rating on the stock in a research note on Wednesday, July 9th.

Agilon Health Trading Down 2.6%

Agilon Health stock opened at $0.95 on Tuesday. The company has a market capitalization of $391.63 million, a P/E ratio of -1.23 and a beta of 0.07. The firm’s fifty day simple moving average is $1.11 and its 200-day simple moving average is $2.07. Agilon Health has a 1-year low of $0.71 and a 1-year high of $6.08.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.14). The business had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The firm’s revenue for the quarter was down 5.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.07) EPS. On average, equities research analysts predict that Agilon Health will post -0.59 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Nisa Investment Advisors LLC grew its stake in Agilon Health by 244.9% in the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock valued at $41,000 after buying an additional 6,783 shares during the last quarter. Gabelli Funds LLC acquired a new stake in Agilon Health in the 1st quarter worth $48,000. Arrowpoint Investment Partners Singapore Pte. Ltd. acquired a new stake in Agilon Health in the 2nd quarter worth $31,000. Ridgecrest Wealth Partners LLC acquired a new stake in Agilon Health in the 1st quarter worth $65,000. Finally, 111 Capital acquired a new stake in Agilon Health in the 2nd quarter worth $36,000.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.